Supported by over two decades of experience in regulatory approval, health-technology-assessment, clinical data generation & commercial sales in Europe and the US, Stratarium Sàrl collaborates with European and US innovative technology medtechs to navigate the complex but highly rewarding single-payer UK healthcare system
Stratarium seeks to work with recently commercialised or pre-commercial technologies that address a clinical need in the UK healthcare system, to then establish a clinical and market development strategy aligned with the manufacturer’s resources
Stratarium’s unique offering is to then invest its own resources and share risk with manufacturers, in exchange for an appropriate return based on agreed objectives
